Emerging Therapeutic Targets for Alzheimer Disease

Howard Fillit, MD, geriatrician, neuroscientist, and Chief Science Officer and Co-Founder of the Alzheimer's Drug Discovery Foundation, discusses the importance of research into new therapeutic targets to develop next-generation treatments for Alzheimer disease, including small molecule compounds.
Learn more about your ad choices. Visit megaphone.fm/adchoices